Your need for quality patient care at low dose with greater productivity and affordability is more important than ever.  That’s why we design CT systems that help you solve your biggest challenges. 
Our family of innovative CT products let you match a system to your exact imaging needs — so you can focus on better patient care. 

GE Healthcare offers the first FDA-approved ultrasound supplemental technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, Invenia ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast.

Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year. According to the WHO, it is estimated that 627,000 women died from breast cancer in 2018 which represents 15 percent of all cancer deaths among women.¹

Your need for quality patient care at low dose with greater productivity and affordability is more important than ever.  That’s why we design CT systems that help you solve your biggest challenges. 
Our family of innovative CT products let you match a system to your exact imaging needs — so you can focus on better patient care.